Double-Filtration Plasmapheresis (German System)德机双重血液净化
德机双重血液净化Double-Filtration Plasmapheresis (German System)
Double-filtration plasmapheresis uses two separation stages. The first separates plasma from blood cells; the second fractionates plasma components. Filter characteristics influence which components are removed or retained.双重滤过血浆分离有两级分离：第一级分离血浆和血细胞，第二级分离血浆组分。滤器特性影响哪些成分被移除或保留。
Hospital named in the catalogue目录所列医院
Clinical details below are in English. Ask the care team for help understanding the source documents.
What to clarify
How assessment and planning work评估与规划如何进行
A German-system proposal still needs the exact separator and fractionator models. Ask which measured abnormality is targeted, what useful change would be expected and whether treatment must be repeated.德国系统方案仍需明确分离器和血浆组分滤器型号，应说明针对哪项异常、如何判断有用变化及是否需重复治疗。
Before your consultation
Proposed device model, target laboratory abnormality, vascular-access history and relevant blood tests.设备型号、目标检验异常、血管通路及血液检查。
Send existing records for an initial discussion. Do not arrange new tests, change medication or book non-refundable travel solely from this page. The receiving team should state which additional information is actually needed.初步沟通可使用已有资料，不应仅凭本页安排新检查、改变用药或预订不可退款的行程。接诊团队应说明确实需要补充的资料。
Evidence and limitations
The manufacturer reference explains the technique, not this unnamed German system. It does not verify benefit for a general anti-ageing course. Access, anticoagulation and changes in blood components require clinical review.制造商资料解释技术，不是核实未明确型号的德国系统，也不证明一般抗衰疗程获益。通路、抗凝和血液成分变化需临床评估。
Questions to ask
How does the proposed German-system filtration course differ?德国系统的双重过滤有什么不同？
The system’s country of manufacture does not determine clinical suitability. Request the filter specifications, treatment target and rationale for a second filtration stage, plus an individualized monitoring plan.制造国不能决定临床适用性。应索取滤器规格、目标、第二级过滤依据和个体化监测。
What should be included in my written treatment plan?书面诊疗方案应包括什么？
The treating team should identify the proposed intervention, alternatives, relevant uncertainty, clinical eligibility, anticipated visits, monitoring and arrangements if the plan changes after assessment. Ask who is responsible for follow-up after you return home.诊疗团队应明确拟议干预、替代方案、相关不确定性、适用条件、预计就诊次数、监测安排及评估后调整方案的处理方式，并说明回国后的随访负责人。
Price and quotation
Ask for an itemized provider quotation after the clinical team reviews your records. The scope may depend on the exact intervention, investigations, consumables, admission and monitoring. Confirm currency, validity period and what happens if the plan changes. Medical fees are paid directly to the provider; Uwell coordination is separate.临床团队审核资料后，可索取机构的分项报价。费用范围可能取决于具体干预、检查、耗材、住院和监测。应确认币种、有效期及方案调整后的计费方式。医疗费用直接向提供机构支付，优健云协调服务另行计费。
Reference catalogueSources and editorial scope
Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.
- NHLBI: bleeding-disorder treatment美国国家心肺血液研究所：出血性疾病治疗
- Asahi Kasei Medical: plasma fractionation equipment and technique旭化成医疗：血浆组分分离设备与技术
The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.临床链接提供背景知识，不代表已核实具体医院项目、当前授权或个体治疗建议，相关信息须由提供机构确认。